The Institute of Medicine has just said that
clinical trial data sharing should become the norm
This institute is a highly respected voice on medical issues in the US and its new report sets a high bar for the future of data sharing. Importantly, the report concludes that “challenges to sharing data – privacy concerns and risks of inappropriate analyses – do not outweigh the benefits and are not barriers to sharing”, AllTrials reports.
Dr Jeffrey Drazen, one of the authors of the report, said:
“We need to recall every day that selfless volunteers put themselves at risk to advance medical science by enabling the data to be gathered. To honour that sacrifice, we need to turn those data into applicable knowledge.”
Read more about what we have said about the report and find links to some of the coverage on AllTrials.net.
— this post is a rearrangement of Ian Bushfield newsletter from AllTrials.net —